Saturday, June 13, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 184 of 1,261
  1. US 11691987

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  2. US 11690898

    Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same

    BIOMARIN PHARMACEUTICAL INC. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  3. US 11690915

    Ras inhibitors

    Revolution Medicines, Inc. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  4. US 11690918

    Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

    ADC THERAPEUTICS SA Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  5. US 11691974

    3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors

    Medshine Discovery Inc. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  6. US 11690933

    Absorbent aliphatic polyurethane foam product

    SENTIENT FOAMS LIMITED Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  7. US 11691011

    Pain-relieving apparatus

    Black Diamond Creations, LLC Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  8. US 11690920

    General and direct method for preparing oligonucleotide-functionalized metal-organic framework nanoparticles

    Northwestern University Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  9. US 11690827

    Methods for treating ocular Demodex using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  10. US 11690921

    Delivery of target specific nucleases

    Sangamo Therapeutics, Inc. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  11. US 11691989

    Macrocyclic indoles as Mcl-1 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  12. US 11692027

    Antibody and protein therapeutic formulations and uses thereof

    The Board of Regents of the University of Texas System Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  13. US 11692176

    Halogenation of complex organic compounds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  14. US 11692010

    Compounds that bind to human immunodeficiency virus rev response element

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  15. US 11692018

    TGF-Ξ² polypeptides

    Cue Biopharma, Inc. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  16. US 11692229

    Fast diagnosis and personalized treatments for acne

    The Regents of the University of California Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  17. US 11692030

    Biomarkers and methods for detection of seizures and epilepsy

    Cognizance Biomarkers, LLC Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  18. US 11693015

    Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function

    Maximus Diagnostic Technologies LLC Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  19. US 11690895

    Compositions and methods of interferon alpha binding proteins

    United States Government as represented by the Department of Veterans Affairs Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  20. US 11690901

    Southern cattle tick vaccine product

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  21. US 11690850

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  22. US 11692032

    Anti-LAG3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  23. US 11690919

    Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells

    The Board of Regents of the University of Texas System Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted
  24. US 11690851

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System Β· Granted Jul 4, 2023 Β· Expires Jun 29, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.